The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Gut-Brain Axis

Ingestible capsule that could help demystify the gut-brain axis
Gut-Brain Axis

Ingestible capsule that could help demystify the gut-brain axis

OCT 26, 2020
Brain Gut Microbiota Axis: A Novel Target for Drug Development
Gut-Brain Axis

Brain Gut Microbiota Axis: A Novel Target for Drug Development

JUL 15, 2020
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Biotics and Supplements

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

NOV 19, 2019
New Research shows link between Parkinson’s disease and the microbiome
Gut-Brain Axis

New Research shows link between Parkinson’s disease and the microbiome

JUL 2, 2019
6 Ways Selected Probiotics Could Help Patients With Parkinson’s Disease
Biotics and Supplements

6 Ways Selected Probiotics Could Help Patients With Parkinson’s Disease

JUN 19, 2019
Gut Microbes Eat Parkinson’s Medication
Editor's Choice

Gut Microbes Eat Parkinson’s Medication

JUN 17, 2019
Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder
Gut-Brain Axis

Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder

MAY 1, 2019
Holobiome Announces Second Collaboration with Johnson & Johnson Innovation
Finance

Holobiome Announces Second Collaboration with Johnson & Johnson Innovation

APR 2, 2019
Newly isolated human gut bacterium reveals possible connection to depression
Gut-Brain Axis

Newly isolated human gut bacterium reveals possible connection to depression

FEB 15, 2019
New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.
Gut-Brain Axis

New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.

NOV 23, 2018
Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers
Gut-Brain Axis

Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers

NOV 13, 2018